Open Access Journal of Gynecology (OAJG)

ISSN: 2474-9230

Review Article

Gestational Trophoblastic Neoplasia

Authors: Wanjari S*

DOI: 10.23880/oajg-16000193

Abstract

Introduction: Gestational trophoblastic neoplasia (GTN) account for less than 1% of cancers of the female reproductive system. Nearly 50% of gestational choriocarcinomas are seen after molar pregnancies. About 25% after abortions or ectopic pregnancy and another 25% after a normal pregnancy. FIGO staging and prognostic scoring index of modified WHO classification is used. Serum β-HCG assay is an important factor in the diagnosis and management of GTN. It is a sensitive tumour marker for GTN and its level is directly related to the number of viable tumour cells. Serial measurement of β-hCG levels is useful for follow-up of women diagnosed with complete or partial mole. An increasing level or plateauing of serum β-hCG is diagnostic of invasive disease which can be invasive mole or choriocarcinoma. Case Report: Patient A-was a 22 year old lady, para1, two year old child which was a normal delivery. She was asymptomatic and reported to the hospital for missed periods. Urine pregnancy test was positive. Ultrasound scan did not find any pregnancy. Beta HCG levels were very high. Then MRI was done which showed no abnormality, other than a bulky uterus. Curettage was done and the report came as trophoblastic tissue seen with possibility of choriocarcinoma. This patient was given 2 cycles of methotrexate with folinic acid after which the patient was lost to follow up. Patient B-was a 27 year old lady, para1, three year old child delivered by caesarean section. She also gave history of two subsequent abortions. She presented with menorrhagia and on examination a cervical polyp was detected. The polyp was resected and sent for histo-pathology and the report suggested choriocarcinoma. Her beta HCG was 30,000. This patient was given three cycles of multi-agent chemotherapy, MAC (Methotrexate, Actinomycin-D and Cyclophosphamide) regime and responded to treatment. Discussion: The main stay of treatment is chemotherapy. Mostly single agent chemotherapy is used methotrexate being the drug of choice. Methotrexate in the dose of 0.4 mg/kg IM or IV daily for 5 days, appears to be the most effective treatment protocol. Another widely used regimen is using folinic acid along with methotrexate. Some of the more commonly used multiagent chemotherapy combinations are – MAC, EMA-CO, EMA-EP, VBP and BEP. Conclusion: GTN can be treated with appropriate chemotherapy and supportive management, after correct staging and scoring of the disease. They are also the most curable of all cancers in women.

Keywords: Gestational Trophoblastic Neoplasia; Chemotherapy; Methotrexate; Prognostic Scoring Index

View PDF

F1 europub scilit.net

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?